PS
ARRY

Portfolio Solutions’s Array Biopharma Inc ARRY Stock Holding History

Portfolio Solutions’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-215
Closed -$4K – 191
2018
Q1 		$4K Sell
215
-110
-34% -$1.76K ﹤0.01% 181
2017
Q4 		$4K Hold
325
– – ﹤0.01% 169
2017
Q3 		$4K Hold
325
– – ﹤0.01% 163
2017
Q2 		$3K Hold
325
– – ﹤0.01% 157
2017
Q1 		$3K Buy
+325
New +$3.46K ﹤0.01% 182

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Portfolio Solutions's ARRY Position: Q2 2018 in Review

Portfolio Solutions sold out of Array Biopharma Inc (ARRY) in Q2 2018, closing a stake of 215 shares — an estimated $4K sold.

Portfolio Solutions first reported a position in ARRY in Q1 2017 and held it in 5 quarters. The position peaked at $4K in Q1 2018. 223 funds tracked by Wall St. Rank hold ARRY as of Q2 2018.

  • Portfolio Solutions reported no remaining Array Biopharma Inc position as of Q2 2018 after selling out during the quarter.
  • Portfolio Solutions sold 215 Array Biopharma Inc shares in Q2 2018, an estimated $4K.
  • Portfolio Solutions first reported a position in Array Biopharma Inc in Q1 2017 and held it in 5 quarters.
  • Portfolio Solutions's Array Biopharma Inc position peaked at $4K in Q1 2018.
  • 223 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q2 2018.

Based on Portfolio Solutions's 13F filing for Q2 2018, filed 13 Jul 2018.